Justine V. Cohen

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis”.

Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2019.11.049

N/A

7.5DataRank · unranked

288 citations

Syed Mahmood, John D. Groarke, Malek Hassan, Anju Nohria, Adam Rokicki +37 more

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Nature Medicine(2023)10.1038/s41591-023-02392-7

N/A

1.6DataRank · unranked

66 citations

Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy U. Lin, Beth Overmoyer +28 more

Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9501

N/A

1.3DataRank · unranked

18 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Teresa M. Petrella +15 more

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

European Heart Journal(2020)10.1093/eurheartj/ehaa051

N/A

0.877DataRank · unranked

346 citations

Magid Awadalla, Syed Mahmood, Anju Nohria, Malek Hassan, Franck Thuny +39 more

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000331

N/A

0.725DataRank · unranked

125 citations

Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate +23 more

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007675

N/A

0.500DataRank · unranked

27 citations

Yevgeniy R. Semenov, Allireza Alloo, Daniel Q. Bach, Allison Betof Warner, Amina Bougrine +36 more

Rejection of benign melanocytic nevi by nevus-resident CD4 + T cells

Science Advances(2021)10.1126/sciadv.abg4498

N/A

0.416DataRank · unranked

15 citations

Scarlett Se Yun Cheon, Seokjin Ham, Heehwa G. Son, Jonathan L. Messerschmidt, Donald P. Lawrence +7 more

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma

Kidney Medicine(2020)10.1016/j.xkme.2020.01.012

N/A

0.345DataRank · unranked

9 citations

Halla Bates, Donald F. Chute, Ian A. Strohbehn, Samuel Strohbehn, Riley Fadden +5 more

Characterizing the tumor and immune landscape of melanoma patients treated with combined checkpoint blockade and MAPK targeted therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9522

N/A

0.326DataRank · unranked

3 citations

Donald P. Lawrence, David F. McDermott, Mofei Liu, Elizabeth I. Buchbinder, Irena Gushterova +14 more

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

Neuro-Oncology(2023)10.1093/neuonc/noad236

N/A

0.323DataRank · unranked

6 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

CTEP 9557: A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF mutant solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3609

N/A

0.293DataRank · unranked

4 citations

James M. Cleary, Justine V. Cohen, Donald P. Lawrence, Elizabeth I. Buchbinder, Anita Giobbie‐Hurder +11 more

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Nature Medicine(2021)10.1038/s41591-021-01386-7

N/A

0DataRank · unranked

520 citations

Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson +55 more

Advanced imaging to assess longitudinal vascular changes in brain metastases treated with immune checkpoint inhibition.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2529

N/A

0DataRank · unranked

0 citations

Ken Chang, Andrew Beers, Kyrre E. Emblem, Jayashree Kalpathy–Cramer, Eudocia Q. Lee +15 more

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100301

N/A

0DataRank · unranked

34 citations

Charu Aggarwal, Janeline Wong, Vivek Nimgaonkar, Wei‐Ting Hwang, Michelle Andronov +17 more

Alliance A071701: Genomically guided treatment trial in brain metastases.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps2573

N/A

0DataRank · unranked

7 citations

Erin Twohy, Carey K. Anders, A. John Iafrate, Peter A. Kaufman, Justine V. Cohen +11 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554868

N/A

0DataRank · unranked

0 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141

N/A

0DataRank · unranked

102 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3116

N/A

0DataRank · unranked

0 citations

Neal P. Smith, Moshe Sade-Feldman, Dennie T. Frederick, Russell W. Jenkins, Justine V. Cohen +13 more

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002007

N/A

0DataRank · unranked

78 citations

Malek Hassan, Amna Zafar, Raza M. Alvi, Magid Awadalla, Syed Mahmood +35 more